Circadian disruption linked with cancer and how

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-09-30 04:15 GMT | Update On 2022-09-30 04:15 GMT

Recent findings highlight that chronic circadian disruption significantly increased lung cancer growth in animal models. By identifying the genes implicated, the researchers are illuminating the mysterious link between our sleeping patterns and disease, which could help inform everything from developing more targeted cancer treatments to better monitoring high-risk groups.

To figure this out the scientists used a mouse model with expressed KRAS-the most commonly mutated gene in lung cancer. Half of the mice were housed in a "normal" light cycle, meaning 12 hours of light and 12 hours of darkness. The other half were housed in a light cycle meant to resemble that of shift workers', where the light hours were moved earlier by eight hours every two or three days.

The findings aligned with what the researchers initially thought: mice that were exposed to the irregular, shifting light patterns had an increased tumor burden of 68%.

But when they used RNA sequencing to determine the different genes involved in the cancer growth, they were surprised that a collection in the heat shock factor 1 (HSF1) family of proteins was the main culprit.

HSF1 genes are responsible for making sure proteins are still made correctly even when a cell is under extreme stress-in this case, when it experiences changes in temperature. The team suspects that HSF1 activity is increased in response to circadian disruption because changes in our sleep cycles disturb the daily rhythms of our bodies' temperature.

With these discoveries in hand, the scientists are now evaluating if HSF1 signaling is required to increase tumor burden and isn't solely just a correlation.

Reference:

Katja Lamia et al JOURNAL Science Advances DOI 10.1126/sciadv.abo1123

Full View

Article Source : Science Advances

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Circadian disruption linked with cancer and how

Similar News

New Urine Test May Detect Prostate Cancer with 91 Percent Accuracy: Study

India Sees Higher Cancer Incidence in Women but Greater Mortality in Men: ICMR Study

This Diet May Cut Risk of Cancer and Heart Disease Multimorbidity: Study Suggests

Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor

One Workout May Trigger Tumor-Suppressing Proteins in Cancer Survivors: Study Shows

New Web-Based Tool Aims to Cut Lung Cancer Deaths with Tailored Strategies, Reveals Research

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu

How COVID-19 May Awaken Dormant Breast Cancer Cells? Study Provides Insights